The ACT EU workplan for 2026 – 2027 has been adopted by the ACT EU Steering Group and is now published.
The workplan reflects the revised ACT EU objectives and takes into account recent legislative and policy developments including the proposed Biotech Act, the Clinical Research Investment Plan (part of the Strategy for European Life Sciences), and the EU4Health initiatives.
The revised workplan outlines activities to strengthen patient involvement, facilitate access to clinical trial data and aim for more inclusive clinical trials. New focus areas also include communication campaigns to encourage the timely submission of clinical trial results and the establishment of a dialogue with stakeholders on the use of artificial intelligence in clinical development.